Adam Friedman, MD, FAAD, discusses essential communication strategies for oncologists to address patient fears about dermatologic adverse effects.
Adam Friedman, MD, FAAD
Advertisement
Articles by Adam Friedman, MD, FAAD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma
2
HDP-101 Receives FDA Fast Track Designation in Multiple Myeloma
3
Collagen Implant May Improve Local Control of Metastatic Brain Tumors
4
FDA Grants Priority Review to Enfortumab Vedotin Combo in MIBC Subset
5
